The merger represents a significant premium and has strong support from the Special Committee and financial advisor. Shareholders should consider voting in favor of the merger proposal. The transaction is expected to close in mid-2026, subject to regulatory and shareholder approval.
Price Chart
Executive Summary
Select Medical Holdings Corporation (SEM) is being acquired by a consortium led by Welsh, Carson, Anderson & Stowe (WCAS) and company executives Robert Ortenzio and Martin Jackson in a going-private transaction. The merger agreement, valued at $2.05 billion, offers $16.50 per share in cash, representing an 18% premium over the unaffected share price. The Special Committee, with assistance from financial advisor Goldman Sachs, unanimously recommended the deal as fair and in the best interests of unaffiliated shareholders. The transaction is expected to close in mid-2026 pending shareholder and regulatory approval.
Key Financial Metrics
Key Facts
- Proposed acquisition price of $16.50 per share in cash
- 18% premium over the unaffected share price of $14.01 as of November 24, 2025
- 25% premium over the 90-day volume-weighted average price
- Goldman Sachs provided a fairness opinion supporting the transaction
- Special Committee unanimously recommended the deal
- Transaction valued at $2.05 billion including equity rollover
Financial Impact
Cash consideration of $16.50 per share, representing an 18% premium over the unaffected price
Risk Factors
- Regulatory approval risk
- Shareholder approval risk
- Potential for competing bids
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| PREM14A Filing (Primary) | 0001104659-26-043505 |
| Document: tm268269d1_ex-filingfees.htm | 0001104659-26-043505 |
| Document: 0001104659-26-043505-index-headers.html | 0001104659-26-043505 |
| Document: 0001104659-26-043505-index.html | 0001104659-26-043505 |
| Document: 0001104659-26-043505.txt | 0001104659-26-043505 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 13, 2026 11w ago | 15-12G | — | awaiting T+1 | — | — |
Jul 1, 2026 13w ago | 25-NSE | $16.52 awaiting T+1 | awaiting T+1 | — | — |
Jul 1, 2026 13w ago | 8-K | $16.52 awaiting T+1 | awaiting T+1 | — | — |
Jun 26, 2026 13w ago | 8-K | $16.53 $16.51 | ▼ −0.12% | ▼ −0.90% | — |
Apr 30, 2026 22w ago | 8-K | $16.38 $16.38 | · 0.00% | ▼ −0.34% | — |
Apr 15, 2026 24w ago | PREM14A | $16.38 $16.39 | ▲ +0.06% | ▼ −0.19% | — |
Mar 4, 2026 30w ago | DEFA14A | $16.25 $16.25 | · 0.00% | ▲ +0.57% | — |
Mar 3, 2026 30w ago | DEFA14A | $16.26 $16.25 | ▼ −0.06% | ▼ −0.82% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access